Marker Therapeutics, Inc. 8-K

What Happened
Marker Therapeutics, Inc. (MRKR) filed a Form 8-K on May 4, 2026 reporting that at its 2026 Annual Meeting of Stockholders the company’s shareholders approved a Charter Amendment to increase the number of authorized shares of Common Stock from 30,000,000 to 130,000,000. The amendment to the Certificate of Incorporation is filed as Exhibit 3.1 to the 8-K.

Key Details

• Share increase: authorized Common Stock raised from 30,000,000 to 130,000,000 shares (an increase of 100,000,000 shares).
• Corporate action approved by stockholders at the 2026 Annual Meeting.
• Amendment to Certificate of Incorporation filed as Exhibit 3.1 to the Form 8-K.
• Form 8-K was filed on May 4, 2026 (Accession No. 0001104659-26-054940).

Why It Matters
Increasing the number of authorized shares gives Marker Therapeutics the legal capacity to issue more common stock in the future for purposes such as financing, equity compensation, or corporate transactions. The 8-K does not disclose any immediate issuances or the company’s plans to use the additional shares—investors should watch future filings (e.g., registration statements or proxy statements) for any share issuances or actions that could affect share count or dilution.